Literature DB >> 9774585

Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates.

D Piérard1, G Muyldermans, L Moriau, D Stevens, S Lauwers.   

Abstract

The sequence of a verocytotoxin 2 (VT2) variant gene that was untypeable by the B subunit PCR and restriction fragment length polymorphism analysis (PCR-RFLP) method described by Tyler et al. (S. D. Tyler, W. M. Johnson, H. Lior, G. Wang, and K. R. Rozee, J. Clin. Microbiol. 29:1339-1343, 1991) was determined and compared with published sequences. It was highly homologous to two recently reported VT2 variant sequences. The PCR-RFLP method described by Tyler et al. was extended to include these new sequences. New VT2 variants were identified in 65 of 359 VT-producing Escherichia coli (VTEC) with newly designed primers (VT2-cm and VT2-f) and were characterized as well by restriction analysis of the amplification products obtained with another VT2-specific primer pair (VT2-e and VT2-f). The VT genes harbored by 64 of these isolates proved to be untypeable by Tyler's PCR-RFLP method because no amplification was obtained with the primers used with this method (VT2-c and VT2-d). The last isolate harbored the new variant gene in addition to VT2vh-a. None of the isolates harboring these new toxin genes belonged to serogroups O157, O26, O103, O111, and O145. All 65 isolates were negative for the eaeA gene and were significantly less frequently enterohemolytic or positive for the enterohemorrhagic E. coli (EHEC) virulence plasmid than non-O157 VTEC isolates harboring other VT2 genes. They were also less frequently isolated from patients with EHEC-associated symptoms. The extended PCR-RFLP typing method is a useful tool to identify less-virulent VTEC isolates and for VT genotyping in epidemiological studies with non-O157 strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774585      PMCID: PMC105321     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli.

Authors:  M P Jackson; J W Newland; R K Holmes; A D O'Brien
Journal:  Microb Pathog       Date:  1987-02       Impact factor: 3.738

2.  Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.

Authors:  S B Calderwood; F Auclair; A Donohue-Rolfe; G T Keusch; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis.

Authors:  S D Tyler; W M Johnson; H Lior; G Wang; K R Rozee
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

4.  Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279.

Authors:  T Meyer; H Karch; J Hacker; H Bocklage; J Heesemann
Journal:  Zentralbl Bakteriol       Date:  1992-01

5.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.

Authors:  D L Weinstein; M P Jackson; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

Review 6.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples.

Authors:  Denis Piérard; Daniel Stevens; Leo Moriau; Hermy Lior; Sabine Lauwers
Journal:  Clin Microbiol Infect       Date:  1997       Impact factor: 8.067

8.  Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Escherichia coli infection.

Authors:  Guy Cornu; Willem Proesmans; Anne Dediste; Frédérique Jacobs; Johan Van De Walle; An Mertens; José Ramet; Sabine Lauwers
Journal:  Clin Microbiol Infect       Date:  1999-01       Impact factor: 8.067

9.  Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction.

Authors:  D R Pollard; W M Johnson; H Lior; S D Tyler; K R Rozee
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

10.  Cloning and sequencing of two new Verotoxin 2 variant genes of Escherichia coli isolated from cases of human and bovine diarrhea.

Authors:  Z Lin; S Yamasaki; H Kurazono; M Ohmura; T Karasawa; T Inoue; S Sakamoto; T Suganami; T Takeoka; Y Taniguchi
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

View more
  85 in total

1.  The nucleotide sequence of Shiga toxin (Stx) 2e-encoding phage phiP27 is not related to other Stx phage genomes, but the modular genetic structure is conserved.

Authors:  Jürgen Recktenwald; Herbert Schmidt
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Enterohemorrhagic Escherichia coli (EHEC) strains of serogroup O118 display three distinctive clonal groups of EHEC pathogens.

Authors:  L H Wieler; B Busse; H Steinrück; L Beutin; A Weber; H Karch; G Baljer
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin.

Authors:  Christine Bürk; Richard Dietrich; Gabriele Açar; Maximilian Moravek; Michael Bülte; Erwin Märtlbauer
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Presence of activatable Shiga toxin genotype (stx(2d)) in Shiga toxigenic Escherichia coli from livestock sources.

Authors:  Kari S Gobius; Glen M Higgs; Patricia M Desmarchelier
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

5.  Genetic typing of shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis.

Authors:  Liesbet De Baets; Imme Van der Taelen; Marina De Filette; Denis Piérard; Lesley Allison; Henri De Greve; Jean-Pierre Hernalsteens; Hein Imberechts
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

6.  Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.

Authors:  Jun Fujii; Mariko Naito; Takashi Yutsudo; Sohkichi Matsumoto; Daniel P Heatherly; Takeshi Yamada; Hideyuki Kobayashi; Shin-Ichi Yoshida; Tom Obrig
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

Review 7.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Induction of Shiga toxin-converting prophage in Escherichia coli by high hydrostatic pressure.

Authors:  Abram Aertsen; David Faster; Chris W Michiels
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

9.  Shedding patterns of verocytotoxin-producing Escherichia coli strains in a cohort of calves and their dams on a Scottish beef farm.

Authors:  D J Shaw; C Jenkins; M C Pearce; T Cheasty; G J Gunn; G Dougan; H R Smith; M E J Woolhouse; G Frankel
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

10.  Characterisation of verotoxin-producing Escherichia coli strains isolated from human patients in Hungary over a 7-year period.

Authors:  T Mag; N Nógrády; M Herpay; I Tóth; F Rozgonyi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.